Cargando…

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

OBJECTIVE: Comorbidities are common in multiple sclerosis (MS) and adversely affect health outcomes. However, the effect of comorbidity on treatment decisions in MS remains unknown. We aimed to examine the effects of comorbidity on initiation of injectable disease-modifying therapies (DMTs) and on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingting, Tremlett, Helen, Leung, Stella, Zhu, Feng, Kingwell, Elaine, Fisk, John D., Bhan, Virender, Campbell, Trudy L., Stadnyk, Karen, Yu, B. Nancy, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826339/ https://www.ncbi.nlm.nih.gov/pubmed/26944268 http://dx.doi.org/10.1212/WNL.0000000000002543

Ejemplares similares

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
por: Kingwell, Elaine, et al.
Publicado: (2015)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
por: McKay, Kyla A, et al.
Publicado: (2016)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
por: McKay, Kyla, et al.
Publicado: (2017)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study
por: Zhang, Tingting, et al.
Publicado: (2017)

Differences in the burden of psychiatric comorbidity in MS vs the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study
por: Evans, Charity, et al.
Publicado: (2021)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Effect of comorbidity on mortality in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity
por: Zhang, Tingting, et al.
Publicado: (2020)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
por: McKay, Kyla A., et al.
Publicado: (2015)

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

A population‐based study comparing multiple sclerosis clinic users and non‐users in British Columbia, Canada
por: McKay, K. A., et al.
Publicado: (2016)

High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis
por: Rotstein, Dalia, et al.
Publicado: (2021)

Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health
por: Razaz, Neda, et al.
Publicado: (2015)

Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
por: Melesse, Dessalegn Y, et al.
Publicado: (2017)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Incidence and prevalence of multiple sclerosis in Europe: a systematic review
por: Kingwell, Elaine, et al.
Publicado: (2013)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
por: Shirani, Afsaneh, et al.
Publicado: (2015)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits
por: Graf, Jonas, et al.
Publicado: (2022)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Evaluating the safety of β-interferons in MS: A series of nested case-control studies
por: de Jong, Hilda J.I., et al.
Publicado: (2017)

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
por: Nickerson, Molly, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7lnpd4ofpvjr0v7u2m203dcufk